2 days Ago By Defense World Staff
Commonwealth Equity Services LLC bought a new stake in Cibus, Inc. ( NASDAQ:CBUS – Free Report ) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 22,201 shares of the company’s stock, valued at approximately $62,000.
Commonwealth Equity Services LLC owned 0.08% of Cibus at the end of the most recent reporting period. A number of other institutional investors also recently bought and sold shares of CBUS.
Wellington Management Group LLP purchased a new stake in Cibus in the 3rd quarter worth $111,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of Cibus by 14.
6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company’s stock worth $161,000 after acquiring an additional 6,276 shares during the last quarter.
IFP Advisors Inc purchased a new stake in shares of Cibus in the 4th quarter valued at $36,000. State Street Corp boosted its stake in shares of Cibus by 43.6% in the third quarter.
State Street Corp now owns 307,262 shares of the company’s stock valued at $1,002,000 after purchasing an additional 93,236 shares during the period. Finally, Barclays PLC raised its stake in shares of Cibus by 287.2% in the third quarter.
Barclays PLC now owns 20,269 shares of the company’s stock valued at $66,000 after acquiring an additional 15,034 shares in the last quarter. 33.81% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes Several research firms recently commented on CBUS. HC Wainwright reissued a “buy” rating and issued a $25.00 target price on shares of Cibus in a report on Friday, March 21st.
Canaccord Genuity Group reduced their price target on Cibus from $20.00 to $18.00 and set a “buy” rating for the company in a report on Wednesday, January 22nd.
Cibus Trading Up 7.1 % Cibus stock opened at $1.81 on Friday.
The stock has a 50-day moving average price of $2.10 and a 200 day moving average price of $3.02.
The stock has a market cap of $59.46 million, a PE ratio of -0.08 and a beta of 1.
83. Cibus, Inc. has a 52 week low of $1.
40 and a 52 week high of $19.56. Cibus ( NASDAQ:CBUS – Get Free Report ) last posted its earnings results on Thursday, March 20th.
The company reported ($0.87) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.68) by ($0.
19). The business had revenue of $1.21 million for the quarter, compared to analyst estimates of $1.
13 million. Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.
78%. On average, equities analysts predict that Cibus, Inc. will post -2.
96 EPS for the current year. About Cibus ( Free Report ) Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Featured Stories Five stocks we like better than Cibus How to trade using analyst ratings JPMorgan is a Buy, if You Can Handle The Volatility TSX Venture Exchange (Formerly Canadian Venture Exchange) United States Steel’s Crash: An Unmissable Buying Opportunity Investing in the High PE Growth Stocks Rocket Lab Stock: Weathering the Storm, Time for a Comeback? Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter ..
